Will Weakness in Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Stock Prove Temporary Given Strong Fundamentals?
Will Weakness in Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Stock Prove Temporary Given Strong Fundamentals?
It is hard to get excited after looking at Micro-Tech (Nanjing)Ltd's (SHSE:688029) recent performance, when its stock has declined 15% over the past three months. However, stock prices are usually driven by a company's financial performance over the long term, which in this case looks quite promising. In this article, we decided to focus on Micro-Tech (Nanjing)Ltd's ROE.
在看到南微医学(南京)股份有限公司(SHSE:688029)近三个月股价下跌15%后，很难感到兴奋。然而，股票价格通常受到公司长期财务表现的影响，在这种情况下，前景看起来相当有希望。在本文中，我们决定专注于南微医学(南京)股份有限公司的roe。
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.
股东要考虑的关键因素之一是净资产收益率或roe，因为它告诉他们公司如何有效地重新投资他们的资本。简单点说，它衡量了公司与股东权益相关的盈利能力。
How Is ROE Calculated?
净资产收益率怎么计算？
The formula for ROE is:
roe的公式是：
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
净资产收益率 = 净利润（从持续经营中获得）÷ 股东权益
So, based on the above formula, the ROE for Micro-Tech (Nanjing)Ltd is:
因此，基于上述公式，南微医学（南京）有限公司的roe为：
14% = CN¥544m ÷ CN¥3.8b (Based on the trailing twelve months to June 2024).
14% = CN¥54400万 ÷ CN¥38亿（基于截至2024年6月的过去十二个月）。
The 'return' is the amount earned after tax over the last twelve months. So, this means that for every CN¥1 of its shareholder's investments, the company generates a profit of CN¥0.14.
“回报”是税后收益在过去十二个月内赚取的金额。因此，这意味着对于每个股东的1元人民币投资，该公司可以创造0.14元人民币的利润。
What Has ROE Got To Do With Earnings Growth?
roe与盈利增长有何关系？
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.
我们已经确定ROE作为评估公司未来收益的有效指标。现在我们需要评估公司为未来增长所保留的利润量，从而给我们一个关于公司增长潜力的想法。假设其他条件都相同，既具有较高ROE又具有较高利润保留的公司通常是增长率更高的公司，相比之下没有这些特点的公司会更低。
A Side By Side comparison of Micro-Tech (Nanjing)Ltd's Earnings Growth And 14% ROE
南微医学（南京）有限公司的盈利增长和14% roe的较旁边的对比
To begin with, Micro-Tech (Nanjing)Ltd seems to have a respectable ROE. Further, the company's ROE compares quite favorably to the industry average of 7.2%. Probably as a result of this, Micro-Tech (Nanjing)Ltd was able to see a decent growth of 16% over the last five years.
首先，南微医学（南京）有限公司的roe似乎还不错。此外，该公司的roe与行业平均水平相比较有优势。可能正是由于此原因，南微医学（南京）有限公司在过去五年间实现了16%的不错增长。
We then compared Micro-Tech (Nanjing)Ltd's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 5.2% in the same 5-year period.
接下来，我们将南微医学（南京）有限公司的净利润增长与行业进行了比较，并很高兴地看到，该公司的增长数据较高，而行业在同一5年期间的增长率为5.2%。
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock's future looks promising or ominous. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if Micro-Tech (Nanjing)Ltd is trading on a high P/E or a low P/E, relative to its industry.
给一家公司附加价值的基础很大程度上与其盈利增长相关。投资者接下来需要确定的是，预期的盈利增长是否已经融入了股价之中。这样做将有助于他们判断股票的未来前景是光明还是不乐观。预期盈利增长的一个很好指标是市盈率，它根据公司的盈利前景确定市场愿意为一只股票支付的价格。因此，您可能想要查看Micro-Tech（南微医学医疗）Ltd的市盈率是高还是低，相对于其所在行业。
Is Micro-Tech (Nanjing)Ltd Efficiently Re-investing Its Profits?
Micro-Tech（南微医学医疗）Ltd是否高效地重新投资其利润？
Micro-Tech (Nanjing)Ltd has a healthy combination of a moderate three-year median payout ratio of 31% (or a retention ratio of 69%) and a respectable amount of growth in earnings as we saw above, meaning that the company has been making efficient use of its profits.
Micro-Tech（南微医学医疗）Ltd在盈利方面有一个健康的组合，三年的中位数派息比率为31%（或留存比率为69%），并且盈利增长相对可观，这意味着该公司一直在有效利用其利润。
Besides, Micro-Tech (Nanjing)Ltd has been paying dividends over a period of four years. This shows that the company is committed to sharing profits with its shareholders.
此外，Micro-Tech（南微医学医疗）Ltd连续四年支付股息。这表明该公司致力于与股东分享利润。
Summary
总的来说，我们对伟明环保的表现非常满意。具体而言，我们喜欢公司以高回报率再投资了其利润的很大一部分。当然，这导致公司的收益大幅增长。但是，最新的行业分析师预测表明，该公司的收益预计将加速增长。
In total, we are pretty happy with Micro-Tech (Nanjing)Ltd's performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see substantial growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings are expected to accelerate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
总体来说，我们对南京南微医学有限公司的表现非常满意。具体来说，我们喜欢该公司以高回报率重新投资其巨额利润，这当然导致了该公司收益的大幅增长。然而，最新的行业分析师预测显示，该公司的收益预计将加速增长。要了解更多关于该公司未来收益增长预测的信息，请查阅这份关于该公司的分析师预测的免费报告。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈？对内容有任何疑虑？请直接与我们联系。或者，发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论，只使用公正的方法论，我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议，也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意，我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。